A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease.
Tuszynski MH; Thal L; Pay M; Salmon DP; U HS; Bakay R; Patel P; Blesch A; Vahlsing HL; Ho G; Tong G; Potkin SG; Fallon J; Hansen L; Mufson EJ; Kordower JH; Gall C; Conner J; Nature Medicine, 2005, vol. 11, issue 5, p 551, ISSN 10788956. ISBN 10788956.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef